Epstein-Barr virus and multiple sclerosis: association or causation? (Q38085337)

28 August 2017

Epstein-Barr virus and multiple sclerosis: association or causation? (English)

1 reference

28 August 2017

0 references

0 references

2

Gavin Giovannoni

1 reference

28 August 2017

Julia Pakpoor

1

1 reference

PubMed ID

23448218

28 August 2017

Sreeram V Ramagopalan

series ordinal

3

1 reference

28 August 2017

1 March 2013

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

28 August 2017

1 reference

28 August 2017

13

1 reference

28 August 2017

287-297

1 reference

28 August 2017

3

1 reference

28 August 2017

1 reference

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

Latent and lytic Epstein-Barr virus replication strategies

21 January 2018

1 reference

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis

21 January 2018

1 reference

Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis

21 January 2018

1 reference

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

21 January 2018

1 reference

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis

21 January 2018

1 reference

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

21 January 2018

1 reference

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

Environmental factors and multiple sclerosis.

21 January 2018

1 reference

Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study

21 January 2018

1 reference

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

21 January 2018

1 reference

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

21 January 2018

1 reference

Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr Virus Reactivation

21 January 2018

1 reference

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

21 January 2018

1 reference

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

21 January 2018

1 reference

Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells

21 January 2018

1 reference

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.

21 January 2018

1 reference

The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.

21 January 2018

1 reference

Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma

21 January 2018

1 reference

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

21 January 2018

1 reference

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.

21 January 2018

1 reference

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis

21 January 2018

1 reference

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

21 January 2018

1 reference

Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein

21 January 2018

1 reference

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

21 January 2018

1 reference

Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis

21 January 2018

1 reference

The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

Just another dubious virus in cells from a patient with multiple sclerosis?

21 January 2018

1 reference

Isolation of retrovirus from patients with multiple sclerosis

21 January 2018

1 reference

Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis

21 January 2018

1 reference

Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.

21 January 2018

1 reference

Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination

21 January 2018

1 reference

Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

21 January 2018

1 reference

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.

21 January 2018

1 reference

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

21 January 2018

1 reference

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.

21 January 2018

1 reference

Cytomorphology of primary CNS lymphoma: review of 23 cases and evidence for the role of EBV.

21 January 2018

1 reference

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

EBV-associated lymphoproliferative disorders: classification and treatment

21 January 2018

1 reference

Rituximab combination therapy in relapsing multiple sclerosis

21 January 2018

1 reference

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

21 January 2018

1 reference

Autoimmune disease: A role for new anti-viral therapies?

21 January 2018

1 reference

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

Epstein-Barr virus: an important vaccine target for cancer prevention

21 January 2018

1 reference

Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge

21 January 2018

1 reference

Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis

21 January 2018

1 reference

Multiple Sclerosis After Infectious Mononucleosis

21 January 2018

1 reference

Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.13.6

1 reference

28 August 2017

1 reference

PubMed ID

23448218